Search research articles
Contact Us
Filters
Showing results (181-190 of 521) with videos related to
Page
of 53
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV
|
July 27, 2025
Efficacy and safety of ME3183, an oral phosphodiesterase 4 inhibitor, in patients with plaque psoriasis
Kim A Papp, April W Armstrong, Tomokazu Koresawa, et al.
JAMA Dermatology
|
February 22, 2013
Standardizing training for psoriasis measures: effectiveness of an online training video on Psoriasis Area and Severity Index assessment by physician and patient raters
April W Armstrong, Kory Parsi, Clayton W Schupp, et al.
Clinical Drug Investigation
|
March 18, 2017
Initiation, Switching, and Cessation of Psoriasis Treatments Among Patients with Moderate to Severe Psoriasis in the United States
April W Armstrong, J Will Koning, Simon Rowse, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
August 13, 2019
Comparison of 2-Octylcyanoacrylate Versus 5-0 Fast-Absorbing Gut During Linear Wound Closures and the Effect on Wound Cosmesis
Anne R Zhuang, Kourosh Beroukhim, April W Armstrong, et al.
The American Journal of Cardiology
|
January 7, 2012
Coronary artery disease in patients with psoriasis referred for coronary angiography
April W Armstrong, Caitlin T Harskamp, Lynda Ledo, et al.
Plos One
|
December 24, 2011
Practice models and challenges in teledermatology: a study of collective experiences from teledermatologists
April W Armstrong, Mei W Kwong, Lynda Ledo, et al.
Journal of the American Academy of Dermatology
|
March 7, 2021
Tapinarof-associated folliculitis is generally mild, self-limiting, and rarely interferes with therapy
Robert Bissonnette, Linda Stein Gold, David S Rubenstein, et al.
Journal of the American Academy of Dermatology
|
March 7, 2021
The preponderance of evidence supports an aryl hydrocarbon receptor-dependent mechanism of action of tapinarof
Robert Bissonnette, Linda Stein Gold, David S Rubenstein, et al.
Dermatology and Therapy
|
October 25, 2024
Matching-Adjusted Indirect Comparison of Risankizumab Versus Deucravacitinib in Patients with Moderate-to-Severe Plaque Psoriasis
April W Armstrong, Ahmed M Soliman, Paolo Gisondi, et al.
Journal of the American Academy of Dermatology
|
July 3, 2021
Mental health outcomes and their association to race and ethnicity in acne patients: A population-based study
Alison H Kucharik, Sarah P Pourali, Jeffrey R Rajkumar, et al.
Page
of 53
Search research articles
Search
Showing results (181-190 of 521) with videos related to
Sort By:
Page
of 53
Journal of the European Academy of Dermatology and Venereology : JEADV
|
July 27, 2025
Efficacy and safety of ME3183, an oral phosphodiesterase 4 inhibitor, in patients with plaque psoriasis
Kim A Papp, April W Armstrong, Tomokazu Koresawa, et al.
JAMA Dermatology
|
February 22, 2013
Standardizing training for psoriasis measures: effectiveness of an online training video on Psoriasis Area and Severity Index assessment by physician and patient raters
April W Armstrong, Kory Parsi, Clayton W Schupp, et al.
Clinical Drug Investigation
|
March 18, 2017
Initiation, Switching, and Cessation of Psoriasis Treatments Among Patients with Moderate to Severe Psoriasis in the United States
April W Armstrong, J Will Koning, Simon Rowse, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
August 13, 2019
Comparison of 2-Octylcyanoacrylate Versus 5-0 Fast-Absorbing Gut During Linear Wound Closures and the Effect on Wound Cosmesis
Anne R Zhuang, Kourosh Beroukhim, April W Armstrong, et al.
The American Journal of Cardiology
|
January 7, 2012
Coronary artery disease in patients with psoriasis referred for coronary angiography
April W Armstrong, Caitlin T Harskamp, Lynda Ledo, et al.
Plos One
|
December 24, 2011
Practice models and challenges in teledermatology: a study of collective experiences from teledermatologists
April W Armstrong, Mei W Kwong, Lynda Ledo, et al.
Journal of the American Academy of Dermatology
|
March 7, 2021
Tapinarof-associated folliculitis is generally mild, self-limiting, and rarely interferes with therapy
Robert Bissonnette, Linda Stein Gold, David S Rubenstein, et al.
Journal of the American Academy of Dermatology
|
March 7, 2021
The preponderance of evidence supports an aryl hydrocarbon receptor-dependent mechanism of action of tapinarof
Robert Bissonnette, Linda Stein Gold, David S Rubenstein, et al.
Dermatology and Therapy
|
October 25, 2024
Matching-Adjusted Indirect Comparison of Risankizumab Versus Deucravacitinib in Patients with Moderate-to-Severe Plaque Psoriasis
April W Armstrong, Ahmed M Soliman, Paolo Gisondi, et al.
Journal of the American Academy of Dermatology
|
July 3, 2021
Mental health outcomes and their association to race and ethnicity in acne patients: A population-based study
Alison H Kucharik, Sarah P Pourali, Jeffrey R Rajkumar, et al.
Page
of 53